DGAP-Adhoc

Epigenomics AG: Capital reduction and further authorization to issue convertible bonds with backstop investor planned - Seite 2

In case that the authorization is exercised, the Company has today concluded a so-called backstop agreement with several shareholders, namely Deutsche Balaton Aktiengesellschaft and its affiliated companies. Under this agreement, Deutsche Balaton Aktiengesellschaft has undertaken, under certain conditions, to subscribe for or acquire new convertible bonds with a total nominal value of up to EUR 4 million if the authorization is exercised.

The complete agenda, together with explanations and more detailed information on registration for the extraordinary General Shareholders' Meeting, can be found in the invitation, which is expected to be published in the Federal Gazette on November 5, 2020 and will also be available at https://www.epigenomics.com/news-investors/general-shareholder-meeting ....
 

Contact:
Company
Epigenomics AG, Geneststrasse 5, 10829 Berlin
Tel [phone], Fax [phone], e-mail: [e-mail]

Investor Relations
IR.on AG, Frederic Hilke, Tel [phone], e-mail: [e-mail]

Forward-looking statements

This publication expressly or implicitly contains certain forward-looking statements concerning Epigenomics AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Epigenomics AG to be materially different from any expected results, performance or achievements expressed or implied by such forward-looking statements. Epigenomics AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

 

---

03-Nov-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---

Language:	English
Company:	Epigenomics AG
	Geneststraße 5
	10829 Berlin
	Germany
Phone:	[phone]
Fax:	[phone]
E-mail:	[e-mail]
Internet:	www.epigenomics.com
ISIN:	DE000A11QW50
WKN:	A11QW5
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID:	1145024